Application 203687

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001FINASTERIDEFINASTERIDETABLET;ORAL1MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
35573-400FinasterideFinasterideBurel Pharmaceuticals, LLCANDACurrent
35573-400FinasterideFinasterideBurel PharmaANDACurrent
35573-400FinasterideFinasterideBurel Pharmaceuticals, Inc.ANDACurrent
35573-400FinasterideFinasterideBurel PharmaANDACurrent
35573-400FinasterideFinasterideBurel Pharmaceuticals, LLCANDACurrent
50436-0927FinasterideFinasterideUnit Dose ServicesANDACurrent
57237-061FinasterideFinasterideRising Health, LLCANDACurrent
57237-061FinasterideFinasterideRising Health, LLCANDACurrent
57237-061FinasterideFinasterideRising Health, LLCANDACurrent
57237-061FinasterideFinasterideRising Health, LLCANDACurrent
65862-927FinasterideFinasterideAurobindo Pharma LimitedANDACurrent
65862-927FinasterideFinasterideAurobindo Pharma LimitedANDACurrent
65862-927FinasterideFinasterideAurobindo Pharma LimitedANDACurrent
65862-927FinasterideFinasterideAurobindo Pharma LimitedANDACurrent
65862-927FinasterideFinasterideAurobindo Pharma LimitedANDACurrent
68071-4808FinasterideFinasterideNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4808FinasterideFinasterideNuCare Pharmaceuticals,Inc.ANDACurrent
68788-6875FinasterideFinasteridePreferred Pharmaceuticals Inc.ANDACurrent
68788-6875FinasterideFinasteridePreferred Pharmaceuticals Inc.ANDACurrent
68788-6875FinasterideFinasteridePreferred Pharmaceuticals Inc.ANDACurrent
68788-6875FinasterideFinasteridePreferred Pharmaceuticals Inc.ANDACurrent
68788-6875FinasterideFinasteridePreferred Pharmaceuticals Inc.ANDACurrent
71335-0281FinasterideFinasterideBryant Ranch PrepackANDACurrent
71335-0281FinasterideFinasterideBryant Ranch PrepackANDACurrent
71335-0281FinasterideFinasterideBryant Ranch PrepackANDACurrent
76420-151FinasterideFinasterideAsclemed USA, Inc.ANDACurrent
76420-153FinasterideFinasterideAsclemed USA, Inc.ANDACurrent